NOVO — September 2025
-
Til JKY og Helge: Helge har ret. Det er 7,2 mg semaglutid. 19% vægttab efter 72 uger. Kilde: (link)
-
Novos diabetespille får opdateret indlægssedlen med hjerte-kar-fordele I EU https://proinvestor.com/investornyt/1361493/novos-diabetespille-far-opdateret-indlaegssedlen-med-hjerte-kar-fordele-i-eu
-
Danske Banks chefhandler om Novo: Positive nyheder skubber aktien op https://proinvestor.com/investornyt/1361532/danske-banks-chefhandler-om-novo-positive-nyheder-skubber-aktien-op
-
WHO backs weight-loss drugs for obesity and urges change in mindset https://www.reuters.com/business/healthcare-pharmaceuticals/who-backs-weight-loss-drugs-obesity-urges-change-mindset-2025-09-15/ Reuters
-
New Molecules and Indications for GLP-1 Medicines https://jamanetwork.com/journals/jama/article-abstract/2838996 JAMA
-
Novo udvider igen paletten af positive effekter ved Wegovy https://proinvestor.com/investornyt/1361784/novo-udvider-igen-paletten-af-positive-effekter-ved-wegovy
-
Novos anbefalingen løftes til "køb" fra "neutral" - kursmålet sænkes af Rothschild https://proinvestor.com/investornyt/1361786/novos-anbefalingen-loftes-til-kob-fra-neutral-kursmalet-saenkes-af-rothschild
-
NOVO: GÅR VIDERE MED CAGRILINTID TIL FASE 3
12:03 -
Novo Nordisk sender vægttabshåb videre i fase 3 https://proinvestor.com/investornyt/1361890/novo-nordisk-sender-vaegttabshab-videre-i-fase-3
-
" - I vores kliniske forsøg har Cagrilintid medført et betydeligt vægttab på en måde, der adskiller sig fra godkendte lægemidler mod fedme, og det ser ud til at være veltolereret." Sakset fra pressemeddelelsen; Spændende nyt: Måske er der nogen, der ved, hvad der gemmer sig bag ordene?
-
FDA sender advarsel til Hims & Hers vedrørende kopier af Novos Wegovy https://proinvestor.com/investornyt/1362018/fda-sender-advarsel-til-hims-hers-vedrorende-kopier-af-novos-wegovy
-
Så har nyheden også ramt EB "Novo vil søge om godkendelse til 'super-Wegovy'" https://ekstrabladet.dk/penge/novo-vil-soege-om-godkendelse-til-super-wegovy/10946464
-
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial https://proinvestor.com/investornyt/1362215/lillys-orforglipron-achieves-significant-weight-loss-in-phase-3-trial
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind